Anzeige
Mehr »
Login
Montag, 28.09.2020 Börsentäglich über 12.000 News von 645 internationalen Medien
Bohrkerne im Prüflabor! Folgt nun der Volltreffer mit Kursexplosion?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
FrNovavax starts first phase 3 COVID-19 vaccine trial in the UK
FrLilly's Verzenio scores a win in early-stage breast cancer
FrFDA sets January decision date for Xalkori in ALK-positive lymphoma
FrQ&A: Isabel Gibson
FrPearls of wisdom
DoUK COVID-19 vaccine 'challenge trials' could intentionally infect participants with virus
DoKeytruda doubles five-year survival rate in NSCLC
DoEMA fast-tracks review of bluebird bio's LentiGlobin for sickle cell disease
DoSurviving cancer: a new era for patients
MiFDA hands BMS and bluebird bio a priority review for ide-cel
MiJanssen's EGFR-targeting treatment regimen shows early benefit in lung cancer
MiRelief Therapeutics seeks US emergency approval for COVID-19 drug
MiCould formulary intelligence be your brand differentiator?
MiHow COVID-19 is accelerating the threat of antimicrobial resistance
DiNew restrictions announced as UK's COVID-19 alert level is increased
DiKeytruda plus chemotherapy cuts risk of death by 27% in advanced oesophageal cancer
DiAZ/Merck's Lynparza improves survival in certain prostate cancers
DiThe flexible salesforce
DiNavigating engagement and remote working during the pandemic
21.09.AZ's Tagrisso cuts risk of EGFR-positive NSCLC spreading to the brain
21.09.BMS eyes approval for second Opdivo combo in kidney cancer
21.09.Pfizer's ALK inhibitor Lorbrena hits the mark in head-to-head lung cancer trial
18.09.BioNTech bolsters COVID-19 vaccine capacity with Novartis deal
18.09.Moderna inks R&D agreements with Vertex and Chiesi
17.09.Eli Lilly reports first results for COVID-19 targeting antibody